Comparison between Lumino Industries IPO and Veeda Clinical Research IPO.
Lumino Industries IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Veeda Clinical Research IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Lumino Industries IPO is up to ₹1,000.00 Cr whereas the issue size of the Veeda Clinical Research IPO is up to ₹0.00 Cr. The final issue price of Lumino Industries IPO is and of Veeda Clinical Research IPO is .
| Lumino Industries IPO | Veeda Clinical Research IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹2 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹600.00 Cr | up to ₹185.00 Cr |
| OFS Issue Size | 0 shares | 1,30,08,128 shares |
| OFS Issue Size (Amount) | up to ₹400.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹1,000.00 Cr | up to ₹0.00 Cr |
Lumino Industries IPO opens on , while Veeda Clinical Research IPO opens on . The closing date of Lumino Industries IPO and Veeda Clinical Research IPO is , and , respectively.
Lumino Industries IPO P/E ratio is , as compared to Veeda Clinical Research IPO P/E ratio of .
| Lumino Industries IPO | Veeda Clinical Research IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 33.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 21.52% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.60% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.95 | 0.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.52% | -0.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Lumino Industries IPO Retail Individual Investors (RII) are offered while in Veeda Clinical Research IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Lumino Industries IPO and in Veeda Clinical Research IPO.
Lumino Industries IPO subscribed in total, whereas Veeda Clinical Research IPO subscribed .
| Lumino Industries IPO | Veeda Clinical Research IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
